Jointown Pharmaceutical (SHA:600998) unit Shandong Jingfeng passed China's generic drug consistency evaluation for trihexyphenidyl hydrochloride tablets.
The anticholinergic drug is used to treat Parkinson's patients and for antipsychotic-induced extrapyramidal reactions, according to a Wednesday filing with the Shanghai bourse.
Shares of the pharmaceutical company were down 2% in recent trade.
Metal Powder Works (ASX:MPW) extended its contract with Westinghouse Electric for a further three months, moving into the next phase of its product development project, according to a Wednesday Australian bourse filing.The next phase of collaboration is expected to take three months, and Metal Powder Works will advance and scale the ability to make powder feedstock via the DirectPowder process.Its shares rose 3% in recent trading on Wednesday.
Beijing is delaying Airbus jet delivery approvals, signaling frustration with European regulators dragging their feet on certifying China's homegrown COMAC aircraft, Reuters reported Tuesday.Sources said the Civil Aviation Administration of China withheld final import and service approvals for Airbus jets for several months, according to the report.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
InSilico Medicine (HKG:3696) said it has not made any concrete decision on a secondary listing at this stage and will make further announcements if there are any material developments, according to a Wednesday Hong Kong bourse filing.Bloomberg reported earlier, citing people familiar with the matter, that the AI-driven drug discovery company was considering a secondary listing in Abu Dhabi, potentially becoming the first company from outside the Gulf to list shares on a regional exchange.The report said InSilico Medicine had held preliminary discussions about a listing on the Abu Dhabi Securities Exchange as early as this year.